...
首页> 外文期刊>Biotechnology and bioprocess engineering >Novel Herbal Medicine C-KOK Suppresses the Inflammatory Gene iNOS via the Inhibition of p-STAT-1 and NF-kB
【24h】

Novel Herbal Medicine C-KOK Suppresses the Inflammatory Gene iNOS via the Inhibition of p-STAT-1 and NF-kB

机译:新草药C-Kok通过抑制p-stat-1和nf-kb来抑制炎症基因Inos

获取原文
获取原文并翻译 | 示例

摘要

Cheong-Pye-Ko (CPK) and Kyung-Ok-Ko (KOK) are traditional herbal medicine prescriptions that have been used in oriental medicine as tonics for pulmonary-related diseases for centuries. However, the effects of a mixture of CPK and KOK (C-KOK) on cytokine-mediated pulmonary damage have not yet been elucidated. This study used lipopolysaccharide (LPS)-activated human pulmonary artery endothelial cells (HPAECs) to examine the effects of C-KOK on the induction of heme oxygenase-1 (HO-1) and the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Moreover, a mouse model was used to determine if C-KOK affected the expression of tumor necrosis factor (TNF)-a and iNOS in the lung tissues of LPS-treated mice. The results showed that C-KOK induced the translocation of Nrf2 from the cytosol to the nucleus by increasing Nrf2-antioxidant response elements (ARE) activity, increased the expression of HO-1, and decreased IL-ip and iNOS/NO production in the LPS-activated HPAECs. Specifically, the suppression of iNOS/ NO expression from the administration of C-KOK was reversed by the RNAi knockdown of HO-1. In conclusion, these findings indicated that C-KOK produced a critical anti-inflammatory effect due to its HO-1 dependent downregulation of p-STAT-1 and NF-kB and the resultant inhibition of iNOS and also suggested that TNF-a was a potential target for HO-1. Therefore, the administration of C-KOK showed efficacy and might be a novel approach for the treatment of inflammatory pulmonary disease.
机译:Cheong-Pye-ko(CPK)和Kyung-Ok-Ko(Kok)是传统的草药处方,以东方药物用作几个世纪以来肺相关疾病的调味品。然而,尚未阐明CPK和KOK(C-KOK)对细胞因子介导的肺损伤的混合物的影响。本研究使用脂多糖(LPS) - 活化的人肺动脉内皮细胞(HPAEC)来检查C-KOK对血红素氧酶-1(HO-1)诱导的影响以及诱导型一氧化氮合酶(INOS)的表达及其表达环氧氧基酶-2(COX-2)。此外,使用小鼠模型来确定C-KOK是否影响了LPS处理小鼠的肺组织中肿瘤坏死因子(TNF)-A和INOS的表达。结果表明,C-KOK通过增加NRF2-抗氧化反应元素(AS)活性,增加HO-1的表达,并降低IL-IP和INOS / NO生产中的C-KOK从细胞溶溶胶到核的易位。 LPS激活的HPAEC。具体地,通过HO-1的RNAi敲低来抑制来自C-KOK的给药的INOS / NO表达。总之,这些研究结果表明,由于其HO-1依赖性下调,C-Kok产生了临界抗炎作用,并且对INOS的合并抑制并表明TNF-A是一个HO-1的潜在目标。因此,C-Kok的给药表现出疗效,并且可能是治疗炎症性肺病的新方法。

著录项

  • 来源
    《Biotechnology and bioprocess engineering 》 |2020年第4期| 536-542| 共7页
  • 作者单位

    Department of Cosmetic Science and Technology Seowon University Cheongju 28674 Korea;

    Dongsan Wonoetangjeonsil Daegu 41472 Korea;

    College of Pharmacy CMRI Research Institute of Pharmaceutical Sciences BK21 Plus KNU Multi-Omics based Creative Drug Research Team Kyungpook National University Daegu 41566 Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    C-KOK; endothelium; iNOS; p-STAT-1;

    机译:C-Kok;内皮;inos;p-stat-1;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号